| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/JMV.1890410503 |
| P698 | PubMed publication ID | 8245887 |
| P2093 | author name string | Elion GB | |
| P2860 | cites work | In vitro susceptibility of varicella-zoster virus to acyclovir | Q28366044 |
| Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir | Q40283127 | ||
| P921 | main subject | aciclovir | Q147101 |
| P304 | page(s) | 2-6 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Journal of Medical Virology | Q15716684 |
| P1476 | title | Acyclovir: discovery, mechanism of action, and selectivity | |
| P478 | volume | Suppl 1 |
| Q30250926 | A core extended naphtalene diimide G-quadruplex ligand potently inhibits herpes simplex virus 1 replication |
| Q36286901 | A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection |
| Q28077334 | A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus |
| Q38110693 | Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. |
| Q64256864 | Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets |
| Q64069942 | An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine |
| Q92622655 | Anti-CyHV-3 Effect of Fluorescent, Tricyclic Derivative of Acyclovir 6-(4-MeOPh)-TACV in vitro |
| Q36280339 | Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids |
| Q38728369 | Anti-Herpes Simplex Virus Type-1 Activity and Phenolic Content of Crude Ethanol Extract and Four Corresponding Fractions of Quercus brantii L Acorn. |
| Q28282376 | Antiviral drug resistance: mechanisms and clinical implications |
| Q41726417 | Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection |
| Q38815225 | Antivirals against animal viruses. |
| Q33726283 | Assays for noninvasive imaging of reporter gene expression |
| Q37713430 | Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence |
| Q59329458 | Cellular Targets for the Treatment of Flavivirus Infections |
| Q41338694 | Clinical investigators as critical determinants in pharmaceutical innovation |
| Q71239712 | Comparative in-vivo genotoxicity of antiviral nucleoside analogues; penciclovir, acyclovir, ganciclovir and the xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay |
| Q34363078 | Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection. |
| Q41990491 | Effects of Antiviral Agent, Acyclovir, on the Biological Fitness of Galleria mellonella (Lepidoptera: Pyralidae) Adults |
| Q99604941 | Efficient Synthesis of α-Branched Purine-Based Acyclic Nucleosides: Scopes and Limitations of the Method |
| Q37835507 | Equine herpesvirus 4: recent advances using BAC technology. |
| Q47690917 | Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans |
| Q40172165 | Evaluation of herpes simplex virus 1 thymidine kinase-mediated trapping of (131)I FIAU and prodrug activation of ganciclovir as a synergistic cancer radio/chemotherapy |
| Q52691809 | Flexibility-Not just for yoga anymore! |
| Q36537841 | HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships |
| Q92860215 | Herpes Simplex Virus, Alzheimer's Disease and a Possible Role for Rab GTPases |
| Q34579981 | Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy |
| Q34531396 | Herpes simplex virus resistance to antiviral drugs |
| Q37182575 | Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography |
| Q43849033 | In vitro antiviral activity of dermaseptins against herpes simplex virus type 1. |
| Q92642157 | Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol |
| Q36624461 | Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template |
| Q24192957 | Intravenous immunoglobulin for the treatment of childhood encephalitis |
| Q41926851 | Intravenous immunoglobulin for the treatment of childhood encephalitis. |
| Q42177738 | KSHV-TK is a tyrosine kinase that disrupts focal adhesions and induces Rho-mediated cell contraction |
| Q37970424 | Management of multidrug-resistant viruses in the immunocompromised host |
| Q40429889 | Mitochondrial toxicity of antiviral drugs |
| Q41107151 | New antiherpesvirus agents. Their targets and therapeutic potential |
| Q37022657 | Non-invasive genetic imaging for molecular and cell therapies of cancer |
| Q44170052 | Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient |
| Q42105578 | Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections |
| Q44800838 | Pharmacokinetics of a single oral dose of acyclovir and valacyclovir in North American box turtles (Terrapene sp.). |
| Q92074796 | Polymeric Electrospun Fibrous Dressings for Topical Co-delivery of Acyclovir and Omega-3 Fatty Acids |
| Q34495644 | Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. |
| Q34149904 | Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management |
| Q59356504 | Structure-Activity Relationships of GAG Mimetic-Functionalized Mesoporous Silica Nanoparticles and Evaluation of Acyclovir-Loaded Antiviral Nanoparticles with Dual Mechanisms of Action |
| Q34113580 | Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines |
| Q40699554 | Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs |
| Q34698954 | Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analogues |
| Q50035154 | Synthesis and cytotoxic activity of novel acyclic nucleoside analogues with functionality in click chemistry. |
| Q73252358 | Synthesis of Novel Imidazo[1,2-a]pyridines with Potent Activity against Herpesviruses |
| Q41919532 | Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses |
| Q35024614 | Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma |
| Q78177468 | The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases. |
| Q52323442 | The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold. |
| Q24242853 | Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection |
| Q24246421 | Third trimester antiviral therapy for preventing recurrent genital herpes at delivery |
| Q37231598 | Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase |
| Q28082910 | Trial Watch: Proteasomal inhibitors for anticancer therapy |
| Q38950995 | UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance |
Search more.